phase i study of anti-her2 car-engineered monocytes in her2-overexpressing solid tumors
Published 1 month ago • 82 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
3:29
autologous macrophages with an anti-her2 car in her2 overexpressing solid tumors
-
4:32
monocytes - low, high, normal values, functions
-
2:08
immunotherapy product animation
-
12:26
what is an allogeneic car t cell?
-
9:50
high monocyte count - monocytosis and low monocytes count
-
57:04
regulation of cns inflammation by astrocytes by dr. francisco quintana
-
3:30
understanding high monocytes: symptoms and causes
-
57:56
live-cell imaging & analysis in immune cell killing, subpopulation identification & 3d cell models
-
49:22
non classical monocytes causing long haul
-
0:56
immunocore t cell killing assays
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:34
easy way to identify monocytes.(easy way to identify monocytes)
-
11:29
multi-parametric quantification of monocytes using live-cell analysis
-
1:44
immunotherapy: how t cells fight cancer
-
8:52
cells of the immune system (part i - granulocytes) (fl-immuno/02)
-
7:40
immunotherapy for aml and all: checkpoint inhibitors & car t-cells for b-cell all
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
1:07:33
a new paradigm for the priming of systemic cd8 t cell responses
-
28:15
completing the immune response
-
1:15
results of phase ii study of tislelizumab in r/r nk/t-cell neoplasms
-
14:09
understanding immunotherapy